Cervical cancer is by far the most common HPV-related disease. About 99.7% of cervical
cancer cases are caused by persistent genital high-risk human papillomavirus (HPV) …

Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

Background and aim Data on type-specific human papillomavirus (HPV) are needed to
investigate HPV-based screening tests and HPV vaccines. However, Chinese relevant data …

Summary Background The Papillomavirus Rapid Interface for Modelling and Economics
(PRIME) has been used around the world to assess the health impact and cost-effectiveness …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer, although
some invasive cervical cancers may test negative by HPV PCR. We previously requested all …

Cervical cancer is considered as an important malignancy among women worldwide.
Currently-used treatments of cervical cancer are reported to be cytotoxic for patients …

Background Human papillomavirus (HPV), one of the most common sexually transmitted
viral infections worldwide, is the leading cause of cervical cancer. In Middle East and North …

Primary prevention through the use of human papillomavirus (HPV) vaccination is expected
to impact both cervical intraepithelial neoplasia (CIN) and adenocarcinoma in situ (AIS) …

The metaplastic epithelium of the transformation zone (TZ) including the squamocolumnar
junction (SCJ) of the uterine cervix is a prime target of human papilloma virus (HPV) …

Human papillomaviruses (HPVs) and the Epstein–Barr virus (EBV) are the most common
oncoviruses, contributing to approximately 10%–15% of all malignancies. Oncoproteins of …